Through the CIBM PET HUG-UNIGE Molecular Imaging Section, a new cutting-edge preclinical Positron Emission Tomography (PET) and Computed Tomography (CT) scanner: the nanoScan PET/CT 122S scanner from Mediso Medical Imaging Systems is available for research.
This state-of-the-art imaging system marks a significant upgrade in the preclinical imaging capabilities of the section, made possible through the generous support of several grants from the Swiss National Science Foundation R’Equip, the Fonds Général de l’UNIGE, the Institut d’Imagerie Moléculaire Translationnelle IIMT Foundation, and contributions from the CIBM itself.
A Leap Forward in Preclinical Imaging Precision
The Mediso nanoScan PET/CT 122S is a powerful tool designed for unparalleled precision and versatility in preclinical research. Its key features include:
- High resolution of 0.7 mm and high sensitivity providing detailed imaging and detecting low count rates down to 60 kBq.
- Large field of view (FOV) allowing whole-body imaging up to 40 cm axially and simultaneous imaging of up to four mice or two rats, significantly improving experimental throughput.
- Seamless multimodal integration for full compatibility with the Mediso nanoScan 3T MRI system of the Preclinical Imaging Facility (PIPPA, UNIGE), enabling multimodal PET/MRI with perfect co-registration of data.
Expanding Research Horizons
The Mediso nanoScan PET/CT 122S will enable to open new doors for cutting-edge, multi-disciplinary research at CIBM, including projects on tumor marker identification and radioligand developments for theranostic strategies, studies on Alzheimer’s disease progression, therapy and its link to liver dysfunction, and the development of non-invasive multimodal metabolic imaging techniques. This remarkable system enables us to tackle more complex scientific questions and achieve a deeper understanding of mechanisms, diagnosis and treatment of diseases, reinforcing our mission to set the standard for excellence in biomedical imaging.
